PCSS Exchange Session 3 – Prepare, Part 1
The strengths and barriers for each community and clinic vary, and there is no one-size-fits-all model for implementing medications for addiction treatment (MAT). Questions you have might have include: What models have been used to successfully scale up MAT for OUD patients? What models have specifically been used to scale up buprenorphine treatment? How do we know which model might work best in a particular setting? This session will review these questions and highlight concrete organizational and administrative steps and processes to consider when defining your own clinic’s needs in treatment delivery. We will discuss the value of developing a MAT implementation plan that includes clinical considerations, process improvement considerations, staffing, and financial considerations.
PCSS Exchange Session 2 – Explore, Part 2
Once your clinical site leadership has demonstrated an interest in exploring buprenorphine or other pharmacotherapies as a treatment option for opioid use disorder (OUD) patients, and you have identified a champion to help lead the effort, what are the next steps? How can you ensure the broader clinical workforce is properly trained and confident in their ability to treat patients using pharmacotherapies? This session will review key clinical components of medications for addiction treatment (MAT), including buprenorphine treatment and its various formulations, clinic-wide implementation of new medications, and staff preparation, readiness and motivation. We will also review organizational capacity to access medication, properly screen and identify patients, and engage community partners and referral resources necessary to ensure OUD patients have access to a continuum of treatment and care services.
Half and Half Waiver Training (Glen Falls, NY)
This training is being held remotely. If interested in attending please contact James Norton at [email protected]
Managing Stress and Burnout: Lessons learned from Viktor Frankl, MD
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
House Calls Without the House: SUD Services at Homeless Camps
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
Navigating Resources During COVID-19
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
Maintaining Patient Engagement During A Pandemic – Logistical and Clinical Considerations
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
Rural MOUD and Home Induction
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
Optimal MOUD prescribing practices for the Future: During the COVID-19 Pandemic and Beyond
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
How COVID-19 Impacts Clinical Practice
Over the next few weeks, PCSS is conducting a series of special Clinical Roundtables to provide you with the information you need as you care for your patients with OUD during the COVID-19 epidemic. The goal of the PCSS Clinical Roundtable is to support interactions among addiction experts and health professionals through an informal “roundtable” conversation. We would like you to submit your questions in advance to facilitate discussion.
